FI54301B - Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat

Info

Publication number
FI54301B
FI54301B FI2123/70A FI212370A FI54301B FI 54301 B FI54301 B FI 54301B FI 2123/70 A FI2123/70 A FI 2123/70A FI 212370 A FI212370 A FI 212370A FI 54301 B FI54301 B FI 54301B
Authority
FI
Finland
Prior art keywords
therapeutic
kinazolinderivat
framework
preparation
therapeutic therapeutic
Prior art date
Application number
FI2123/70A
Other languages
English (en)
Other versions
FI54301C (fi
Inventor
Shigeho Inaba
Michiro Yamamoto
Kikuo Ishizumi
Kazuo Mori
Hisao Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP653170A external-priority patent/JPS5138714B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of FI54301B publication Critical patent/FI54301B/fi
Application granted granted Critical
Publication of FI54301C publication Critical patent/FI54301C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI2123/70A 1969-08-02 1970-07-31 Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat FI54301C (fi)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP6122269 1969-08-02
JP6187269 1969-08-04
JP7045369 1969-09-04
JP9883669 1969-12-08
JP9919669 1969-12-09
JP10281069 1969-12-19
JP653170A JPS5138714B1 (fi) 1970-01-23 1970-01-23
JP662870 1970-01-24
JP1406970 1970-02-17

Publications (2)

Publication Number Publication Date
FI54301B true FI54301B (fi) 1978-07-31
FI54301C FI54301C (fi) 1978-11-10

Family

ID=27576527

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2123/70A FI54301C (fi) 1969-08-02 1970-07-31 Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat

Country Status (12)

Country Link
US (1) US3712892A (fi)
CH (3) CH553190A (fi)
DE (1) DE2037693C3 (fi)
DK (1) DK127556B (fi)
FI (1) FI54301C (fi)
FR (1) FR2060075B1 (fi)
GB (1) GB1313789A (fi)
IL (1) IL35035A (fi)
NL (1) NL151704B (fi)
NO (1) NO128277B (fi)
PL (1) PL81273B1 (fi)
YU (1) YU3277A (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925359A (en) * 1967-03-30 1975-12-09 Hoffmann La Roche Novel 2{8 2-(1,3-diazacycloalk-2-enyl){9 benzophenone derivatives and novel 1,3-diazacycloalkenyl{8 2,1-1{9 isoindole derivatives
US3929766A (en) * 1967-03-30 1975-12-30 Hoffmann La Roche Novel 2{8 2-(1,3-diazacycloalk-2-enyl){9 benzophenone derivatives and novel 1,3-diazacycloalkenyl{8 2,1-A{9 isoindole derivatives
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DK129348B (da) * 1970-07-13 1974-09-30 Sumitomo Chemical Co Analogifremgangsmåde til fremstilling af 1-substituerede 3,4-dihydro-2(1H)-quinazolinonderivater.
DE2050640A1 (de) * 1970-10-15 1972-04-20 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des (lH,3H)-Chinazolin-2-thion-4-ons
DE2162327C3 (de) * 1970-12-23 1975-09-18 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
DK135044B (da) * 1971-05-06 1977-02-28 Sandoz Ag Analogifremgangsmåde til fremstilling af 4-phenyl- eller 4-(2'-thienyl)-6,7-methylendioxy-2(1H)-quinazolinoner eller -2(1H)-quinazolinthioner.
US4202895A (en) * 1971-06-04 1980-05-13 Sumitomo Chemical Company, Limited 1-Polyhaloalkyl-2(1H)-quinazolinone derivatives
BE795519A (fr) * 1972-02-18 1973-06-18 Sumitomo Chemical Co Procede de preparation d'un agent uricosurique
JPS5426556B2 (fi) * 1972-03-24 1979-09-04
JPS5427356B2 (fi) * 1972-03-31 1979-09-10
DE2225218C2 (de) * 1972-05-24 1983-01-13 Morishita Pharmaceutical Co., Ltd., Osaka 2-Alkyl-4-äthoxy-5-morpholino-3(2H)-pyridazinone und Verfahren zu deren Herstellung
JPS5418269B2 (fi) * 1972-07-20 1979-07-06
JPS5537554B2 (fi) * 1972-07-24 1980-09-29
JPS555506B2 (fi) * 1972-09-07 1980-02-07
US4067868A (en) * 1973-04-17 1978-01-10 Sumitomo Chemical Company, Limited Production of quinazolinone compounds
US3927011A (en) * 1973-05-10 1975-12-16 Yoshitomi Pharmaceutical 2-Aminoalkyl-1-(pyridylcarbonylphenyl)imidazole compounds
JPS5724789B2 (fi) * 1973-08-14 1982-05-26
JPS5046680A (fi) * 1973-08-20 1975-04-25
GB1494340A (en) * 1974-12-03 1977-12-07 Wyeth John & Brother Ltd Process for preparation of substituted n-phenylcarbamate esters
JPS521036A (en) 1975-06-23 1977-01-06 Sumitomo Chem Co Ltd Antiphlogistic with extremely low reaction to digestive canals
US4247554A (en) * 1977-05-11 1981-01-27 Sumitomo Chemical Company, Limited Method for the prevention of gastro-intestinal ulcer caused by a non-steroidal anti-inflammatory agent
AR038658A1 (es) * 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
GB0230015D0 (en) 2002-12-23 2003-01-29 Novartis Ag Organic compounds
WO2005042501A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
US20070111906A1 (en) * 2005-11-12 2007-05-17 Milner Jeffrey L Relatively low viscosity transmission fluids
US7682491B2 (en) * 2007-03-26 2010-03-23 Nalco Company Antifoulant for hydrocarbon processing equipment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO56665A (fi) * 1968-07-01 1974-06-01

Also Published As

Publication number Publication date
DE2037693A1 (de) 1971-02-25
NL151704B (nl) 1976-12-15
IL35035A0 (en) 1970-09-17
DE2037693B2 (de) 1974-05-22
IL35035A (en) 1973-01-30
DK127556B (da) 1973-11-26
CH554877A (de) 1974-10-15
FR2060075B1 (fi) 1974-08-30
YU3277A (en) 1982-06-30
CH553190A (de) 1974-08-30
GB1313789A (en) 1973-04-18
DE2037693C3 (de) 1975-01-16
FR2060075A1 (fi) 1971-06-11
US3712892A (en) 1973-01-23
PL81273B1 (en) 1975-08-30
FI54301C (fi) 1978-11-10
CH553791A (de) 1974-09-13
NL7011359A (fi) 1971-02-04
NO128277B (fi) 1973-10-22

Similar Documents

Publication Publication Date Title
FI54301B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
BG18599A3 (bg) Метод за получаване на бета-арил-2-аминоалкоксистироли
FI53897B (fi) Ljuskaensliga foereningar och foerfarande foer framstaellning av dessa
BG17749A3 (bg) Метод за получаване на фенокси-2-хидрокси -3- циклоалкиламинопропани
FI55184C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer
IT1033044B (it) Procedimento per la preparazione di ciclosilossani
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
FI54602C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-amidinopenicillansyraderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
FI54104B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma pyrrolidinonfoereningar
BE749006A (fr) Preparation de polyalcenameres
FI53700C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE380796B (sv) Forfarande for framstellning av cyklopentanderivat
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol
NO137050C (no) Fremgangsm}te til fremstilling av butyrofenonderivater
FI56171B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva asylerade piperidin-, tetrahydropyridin- och pyridinderivat
BE753379A (fr) Preparation de lysergols